Unknown NA INTERVENTIONAL 2-arm NCT03798028

The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis

The Effects and Safety of Mesenchymal Stem Cells in the Treatment of Moderate/Severe Rheumatoid Arthritis， a Multicenter Randomized Controlled Clinical Study

Sponsor: Changhai Hospital

Conditions Rheumatoid Arthritis

Interventions UC-MSCs

Updated 4 times since 2019 Last updated: Jan 7, 2019 Started: Dec 26, 2017 Primary completion: Dec 31, 2019 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Rheumatoid Arthritis, this trial is ongoing. The trial is conducted by Changhai Hospital and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Feb 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital
Southwest Hospital, China
Xijing Hospital

Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China